article thumbnail

Abbott Enters IVL Burgeoning Segment

CardiacWire

Intravascular lithotripsy (IVL) may have once been synonymous with Shockwave Medical, but its now rapidly becoming one of the hottest segments in interventional cardiology, spurred on by Abbotts new IVL Investigational Device Exemption (IDE) from the FDA.

Plaque 59
article thumbnail

Boston Scientific Receives FDA Approval for the AGENT Drug-Coated Balloon

DAIC

"With more than 100,000 patients treated globally to date in both clinical and commercial settings, we are very pleased to introduce this proven therapy as the first drug-coated coronary balloon in the U.S," said Lance Bates , president, Interventional Cardiology Therapies, Boston Scientific. vs. 28.7%; P=0.006).

Stents 105
article thumbnail

ECG Blog #415 — The Cath showed NO Occlusion!

Ken Grauer, MD

Figur e-4: Classification of Underlying Diagnoses in Patients with MINOCA ( Adapted from Table-1 in Sykes et al: Interventional Cardiology Review: 16:e10, 2021 ). Cardiac MRI ( especially with the addition of LGE ) provides insight to longterm prognosis of patients with MINOCA.

Blog 162
article thumbnail

Impact of untreated CAD on TAVR outcomes

Cardiology Update

Conducted as a retrospective cohort study from January 2015 to November 2021, TAVR recipients were categorized based on the presence of stable non-obstructive or varying degrees of obstructive CAD.

TAVR 115
article thumbnail

Radial Versus Femoral Access for Mechanical Thrombectomy in Stroke Patients: A Non-Inferiority Randomized Clinical Trial

Stroke Journal

Following the interventional cardiology guidelines, routine transradial access has been proposed as an alternative, although its safety and efficacy remain controversial. Stroke, Ahead of Print. Background:Transfemoral access is predominantly used for mechanical thrombectomy in stroke patients with a large vessel occlusion.

Stroke 40
article thumbnail

VahatiCor, Inc. Announces Treatment of First Patient with the A-FLUX Reducer System Innovation for Patients Suffering from Angina Due to Persistent Ischemic Heart Disease

DAIC

It was an honor to perform the first-in-human implant and the patient is doing great,” said Dr. Jean-Michel Paradis , specialist in coronary and structural interventional cardiology at Quebec Heart and Lung Institute , who co-treated the first patient. 27 May 2021. The A-FLUX Reducer could help to fill that therapeutic void.

Angina 59
article thumbnail

Abstract WP242: Comparison Between Right and Left Transradial Approach for Carotid Artery Stenting Using a 6-French Simmons Guiding Sheath

Stroke Journal

However, in interventional cardiology, the left TRA has demonstrated clear clinical benefits, particularly for right-handed patients. The right TRA was performed as a first-line approach from 2019 to 2021, with the left TRA being used thereafter. Typically, the right radial artery is used in neurointerventions.

Stents 40